The rising interest in GLP-1 agonists for weight control has led to a debate about application forms : transdermal systems versus tablets . Traditionally , GLP-1 treatments were exclusively available in https://aoifebwbk499518.aioblogs.com/93658388/glp-1-transdermal-delivery-systems-vs-oral-medications-is-best-for-the-patient